[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2110998T3 - Procedimiento para la determinacion de las trombopenias. - Google Patents

Procedimiento para la determinacion de las trombopenias.

Info

Publication number
ES2110998T3
ES2110998T3 ES91915653T ES91915653T ES2110998T3 ES 2110998 T3 ES2110998 T3 ES 2110998T3 ES 91915653 T ES91915653 T ES 91915653T ES 91915653 T ES91915653 T ES 91915653T ES 2110998 T3 ES2110998 T3 ES 2110998T3
Authority
ES
Spain
Prior art keywords
determination
inducer drug
thrombocytopeniae
inducer
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915653T
Other languages
English (en)
Inventor
Jean Amiral
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostica Stago SAS
Original Assignee
Diagnostica Stago SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostica Stago SAS filed Critical Diagnostica Stago SAS
Application granted granted Critical
Publication of ES2110998T3 publication Critical patent/ES2110998T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Record Carriers (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA DETERMINACION DE TROMBOCITOPENIAS INDUCIDAS POR UNA DROGA INDUCTORA. SEGUN LA INVENCION, SE UTILIZA PARA DICHA DETERMINACION UNA SUSTANCIA ANTIGENICA ELEGIDA ENTRE EL CONJUNTO CONSTITUIDO POR LAS FRACCIONES QUE (I) ESTAN PRESENTES EN LAS PLAQUETAS SANGUINEAS Y LIBERADAS DE DICHAS PLAQUETAS SANGUINEAS POR LISIS, Y (II) TIENEN UNA GRAN AFINIDAD RESPECTO DE LA DROGA INDUCTORA (Z) Y/O DE LOS COMPLEJOS DE DICHA DROGA INDUCTORA CON LAS PLAQUETAS, ESTANDO DESTINADA DICHA SUSTANCIA ANTIGENICA A REACCIONAR CON UN MATERIAL ANTICUERPO ANTI (Y) CONTENIDO EN EL PLASMA A PROBAR Y DIRIGIDO CONTRA LA DROGA INDUCTORA, SUS FRAGMENTOS O LOS PRODUCTOS QUE CONTIENEN DICHA DROGA INDUCTORA O UNO DE SUS FRAGMENTOS. LA INVENCION SE REFIERE TAMBIEN A UN PROCESO PARA LA DETERMINACION DE DICHAS TROMPOCITOPENIAS, EN PARTICULAR LAS INDUCIDAS POR HEPANIMA.
ES91915653T 1990-08-09 1991-08-09 Procedimiento para la determinacion de las trombopenias. Expired - Lifetime ES2110998T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9010190A FR2665769B1 (fr) 1990-08-09 1990-08-09 Determination des thrombopenies notamment induites par l'heparine au moyen du facteur plaquettaire 4.

Publications (1)

Publication Number Publication Date
ES2110998T3 true ES2110998T3 (es) 1998-03-01

Family

ID=9399577

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915653T Expired - Lifetime ES2110998T3 (es) 1990-08-09 1991-08-09 Procedimiento para la determinacion de las trombopenias.

Country Status (7)

Country Link
EP (1) EP0495971B1 (es)
JP (1) JP2821951B2 (es)
AT (1) ATE160448T1 (es)
DE (1) DE69128238T2 (es)
ES (1) ES2110998T3 (es)
FR (1) FR2665769B1 (es)
WO (1) WO1992002823A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585243A (en) * 1993-09-15 1996-12-17 The Blood Center Of Southeastern Wisconsin, Inc. Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells
US5972717A (en) * 1995-05-10 1999-10-26 The Blood Center Research Foundation, Inc. Method and kit for detecting heparin induced thrombocytopenia
FR2738916B1 (fr) * 1995-09-20 1997-11-14 Stago Diagnostica Procede d'identification precoce d'une maladie auto-immune, utilisation dans le domaine du diagnostic et necessaire de dosage pour mettre en oeuvre ce procede
JP2001504584A (ja) * 1996-11-21 2001-04-03 メルク エンド カンパニー インコーポレーテッド 拮抗薬依存性ＧＰＩＩｂ／ＩＩＩａレセプタ抗体の検出
US20060172438A1 (en) 2004-10-04 2006-08-03 David Milunic Methods and kits for detecting heparin/platelet factor 4 antibodies
US9322825B2 (en) * 2008-08-27 2016-04-26 Lsi Medience Corporation Modified anti-heparin/PF4 complex antibody and HIT antibody standard
EP3438667B1 (de) * 2017-08-02 2020-12-30 Siemens Healthcare Diagnostics Products GmbH Bindungstest zur diagnose einer heparin-induzierten thrombozytopenie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay

Also Published As

Publication number Publication date
DE69128238T2 (de) 1998-06-25
ATE160448T1 (de) 1997-12-15
EP0495971A1 (fr) 1992-07-29
DE69128238D1 (de) 1998-01-02
FR2665769B1 (fr) 1994-04-29
EP0495971B1 (fr) 1997-11-19
JP2821951B2 (ja) 1998-11-05
JPH05502103A (ja) 1993-04-15
WO1992002823A1 (fr) 1992-02-20
FR2665769A1 (fr) 1992-02-14

Similar Documents

Publication Publication Date Title
FI871288A (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
DE69228701D1 (de) Fragmente von Prion Proteinen.
NO964982D0 (no) Detektering av reticulocytter
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
ATE194921T1 (de) Verfahren zur inaktivierung von viren
ATA188090A (de) Verfahren zur verarbeitung von tabakblättermaterial, damit erhaltenes tabakmaterial und dieses enthaltende rauchartikel
PT98113A (pt) Processo para a preparacao de proteinas de fusao com uma fraccao de imunoglobulina
ES553015A0 (es) Dispositivo para la separacion selectiva de fracciones de especies patologicas y-o toxicas macromoleculares de sangre o de componentes de la sangre
ES2098406T3 (es) Ensayo funcional y reactivo para la determinacion de fibrinogeno.
ATE170982T1 (de) Inhibitoren zur antikoagulierenden vorbehandung von blutproben
UA24003A (uk) Спосіб визhачеhhя специфічhої сеhсибілізації лімфоцитів
ES2110998T3 (es) Procedimiento para la determinacion de las trombopenias.
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
Binette et al. The proteins of synovial fluid: A study of the α1/α2 globulin ratio
ES2053669T3 (es) Agente para diagnostico y procedimiento para la determinacion de apolipoproteina b.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
Sehon et al. Electrophoretic separation of skin-sensitizing antibody from the sera of ragweed-sensitive patients
DK0683791T3 (da) Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ES482215A1 (es) Mejoras en un metodo de radioinmunoanalisis del factor de - plaquetas y en el plasma sanguineo.
ATE147861T1 (de) Funktioneller test zur bestimmung der protein s- aktivität
Fiedel et al. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 495971

Country of ref document: ES